
IndraLab
Statements
sparser
"Segmental duplications (SDs), which are considered a common phenomenon and account for approximately 7% (or 218 Mbp) of the human genome [ xref ], have been reported to be associated with the formation of chimeric fusion genes, such as BCR::ABL1 through t(9;22)(q34;q11.2) [ xref ] and RUNX1::USP42 through ins(21;7)(q22;p15p22) [ xref ], in myeloid malignancies."
sparser
"The remaining patients harbored already reported fusions that do not impact our current treatment protocols ( STIL::TAL1, RBM15::MKL1, PICALM::MLLT10 ) and novel fusions recently reported in the literature with potential or clinical impact in therapeutic protocols [ P2RY8::CRLF2, MEF2D::BCL9, MEF2D::CSF1R, ETV6::ABL1, TCF3::ZNF384, PAX5::NOL4L, RUNX1::CBFA2T3, RUNX1::USP42 , and TBL1XR1::TP63 ( xref )]."
sparser
"In the same line, some of the most recurrent fusion genes in pediatric leukemia were found in our cohort ( ETV6::RUNX1, STIL::TAL1, KMT2A -rearrangements, RUNX1::RUNX1T1, BCR::ABL1 ), as well as other novel rearrangements described, most of them associated with BCP-ALL B-other subtypes ( MEF2D::BCL9, MEF2D::CSF1R, ETV6::ABL1, TCF3::ZNF384, and PAX5::NOL4L ) or to rare and/or recent AML fusions reported in the literature ( RUNX1::CBFA2T3, RBM15::MKL1, RUNX1::USP42, and TBL1XR1::TP63 ) ( xref ; xref ; xref )."
sparser
"Whole-genome sequencing identified cytogenetically cryptic structural variants in 13 patients, including complex or cryptic chromosomal translocations involving the inv(16)(p13.1q22) fusion gene CBFB–MYH11 in 2 patients, the t(7;21) (p22;q22) fusion gene USP42–RUNX1 in 1 patient, and 10 rearrangements involving KMT2A , all of which were verified with the use of orthogonal methods ( xref and xref , xref , and xref in the xref )."
sparser
"The patients in the remaining cluster, carried various nonrecurrent rearrangements, including BCL11B rearrangements (n=2), CBFB-MYH11 (n=2), ETV6-MECOM (n=1), KMT2A-MLLT10 (n=1), MECOM (n=1), NUP98-HOXA13 (n=1), SFPQ-ZFP36L2 (n=1), MED12-HOXA9 (n=1), PIM1-BRD1 (n=1), CBFA2T3-GLIS2 (n=1), PICALM-MLLT10 (n=1), RUNX1-USP42 (n=1)."
sparser
"Of note, del(5q) occurs as a secondary abnormality in at least two subtypes of AML with cryptic abnormalities: t(5;11)(q35;p15)/ NUP98-NSD1 and the rare t(7;21)(p22;q22)/ RUNX1-USP42 , thus emphasizing the need for a complete cytogenetic and molecular screening of such cases [ xref , xref , xref ]."